|

MHB088C for Injection Clinical Trials

3 actively recruiting trials

Pipeline

Phase 3: 1Phase 1/2: 2

Top Sponsors

  • Qilu Pharmaceutical Co., Ltd.2
  • Minghui Pharmaceutical (Hangzhou) Ltd1

Indications

  • Cancer3
  • Advanced/Metastatic Solid Tumors1
  • Small Cell Lung Cancer Extensive Stage1
  • Advanced Malignant Solid Tumor1
  • Lung Cancer1

Other3 trials

A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors
Phase 1/2
A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Phase 3
Study of MHB088C for Patients With Advanced Solid Malignant Tumors
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.